Preethi Sundaram - Net Worth and Insider Trading
Preethi Sundaram Net Worth
The estimated net worth of Preethi Sundaram is at least $0 dollars as of 2024-11-13. Preethi Sundaram is the Chief Strategy Officer of Catalyst Pharmaceuticals Inc and owns about 0 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $0. Details can be seen in Preethi Sundaram's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Preethi Sundaram has not made any transactions after 2022-11-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Preethi Sundaram
Preethi Sundaram Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Preethi Sundaram owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of Preethi Sundaram’s form 4 insider trades.
Insider Ownership Summary of Preethi Sundaram
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2022-11-11 | Chief Product Devel. Officer |
Preethi Sundaram Latest Holdings Summary
Preethi Sundaram currently owns a total of 1 stock. Preethi Sundaram owns 0 shares of Catalyst Pharmaceuticals Inc (CPRX) as of November 11, 2022, with a value of $0.
Latest Holdings of Preethi Sundaram
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2022-11-11 | 0 | 23.04 | 0 |
Holding Weightings of Preethi Sundaram
Preethi Sundaram Form 4 Trading Tracker
According to the SEC Form 4 filings, Preethi Sundaram has made a total of 2 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 56,786 shares on November 11, 2022, which brought Preethi Sundaram around $930,155.
Insider Trading History of Preethi Sundaram
- 1
Preethi Sundaram Trading Performance
Preethi Sundaram Ownership Network
Ownership Network List of Preethi Sundaram
Ownership Network Relation of Preethi Sundaram
Preethi Sundaram Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Preethi Sundaram is the Chief Product Devel. Officer of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include VP Development & Management Steve Miller , Chief Commercial Officer Carmen Jeffrey Del , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Preethi Sundaram made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 230,000 shares made by Gary Ingenito , a net sale of 90,000 shares made by David S Tierney , and a net sale of 190,000 shares made by Steve Miller .
In summary, during the past 3 months, insiders sold 165,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 165,000 shares. During the past 18 months, 741,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 741,406 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Preethi Sundaram Mailing Address
Above is the net worth, insider trading, and ownership report for Preethi Sundaram. You might contact Preethi Sundaram via mailing address: 355 Alhambra Circle, Suite 801, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
